A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...
Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...
Faculty profile for Dr. Steven Blinka. Dr. Blinka is a board-certified medical oncologist whose research focuses on understanding the genetic drivers of disease, response and treatment resistance in ...
The SeattleStatGROWS program (Statistical Growing Research Opportunities for Undergraduates in Washington State) is a Fred ...
In this episode of Oncology Insights, Dr. Petros Grivas and Dr. Rachael Safyan discuss the advancements in gastrointestinal ...
CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...
After surgery for prostate cancer, Todd Elworthy’s PSA came back elevated. Radiation was advised as the next step and Elworthy looked into a Fred Hutch clinical trial and proton therapy. Though he ...
ASH will recognize Rainer Storb, MD, with the Wallace H. Coulter Award for Lifetime Achievement in Hematology, the society's highest honor. See below for summaries and links to selected Fred Hutch ...
You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...
The special properties of methylcellulose foam could make it a vehicle for bedside genetic engineering, according to a proof-of-principle study from bioengineers at Fred Hutch Cancer Center. In the ...
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding SEATTLE – Oct. 2, 2024 – Four National Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results